FDAnews Announces Social Media Strategies for Drug & Device Companies Virtual Conference

FALLS CHURCH, Va., May 14, 2013 /PRNewswire-iReach/ -- Social Media Strategies for Drug & Device Companies
Practical Tips and Tools to Use in the Absence of FDA Guidance
**Virtual Conference**
May 30, 201310:00 a.m.2:30 p.m. EDT

(Photo: http://photos.prnewswire.com/prnh/20130514/CG13147)

The head of the FDA's Office of Prescription Drug Promotion (OPDP), Tom Abrams, recently said that one of the FDA's highest priorities is guidance on social media.

But the question is when?  While no date has been provided, Abrams did say the FDA's intent is to meet the July 2014 deadline required by FDASIA.

But, what can drug- and device-makers do in the interim? Where can they turn NOW to take advantage of social media's marketing capabilities without incurring FDA fallout?

The answer: Attend this Virtual Conference to find out what you can – and can't – do to establish an immediate social media presence, starting TODAY.

Register Today

Facebook, Twitter, YouTube. They ought to represent the marketing breakthrough of the new century. But so far, they're techniques that could cause you trouble.

While there has been lots of talk, the lack of FDA guidance has left drug- and device-makers in the dark — and vulnerable to sanctions.

Can drug- and device-makers tap social media before the July 2014 guidance?  The answer is yes — when you know what you're doing.

Clear your calendar for Thursday, May 30 and plan to spend the day near a computer screen. FDAnews will broadcast its highly successful Virtual Social Media Conference featuring top experts in marketing, advertising, technology, regulation and law.

Register Now

You'll discover the OPDP's thinking on issuance of that long-awaited social media guidance — the issues, the hang-ups, the dilemmas and, most important what you can and can't do now.

You'll pick up pointers on selling social media to your bosses — arguments that convince decisionmakers on the potential rewards of these new advertising and marketing channels.

Small and mid-sized drug and device companies will gain from successes of the big boys, with case studies of successful programs and issues to watch out for.

Lack a clue on how to measure the impact of social media campaigns? Learn how to identify definable points for scoring the victories and the flops, and put numbers to intangibles such as user comments.

We've scheduled an entire panel on moderating Facebook pages for adverse events and maintaining page security. In it, you'll discover how to keep Facebook discussions rolling while complying with AER requirements ... distinguish between mere dissatisfaction and actual adverse events ... and much more.

View the lineup of the Virtual Conference

Who Will Benefit

Every marketing, advertising and communications specialist in your organization is a candidate to participate in this Virtual Conference. So are general and outside counsel, regulatory and compliance staff, and top management, too. You'll even want to notify the folks you work with at ad, marketing and tech/IT consulting firms. Spread the word!

Conference Details

Social Media Strategies for Drug & Device Companies
Practical Tips and Tools to Use in the Absence of FDA Guidance
**Virtual Conference**
May 30, 201310:00 a.m.2:30 p.m. EDT

Tuition: $1,297 per site -- includes virtual conference registration and audio cds and transcripts

4 Easy Ways to Register

Online:      www.fdanews.com/SocialMedia
By phone: 888-838-5578 or 703-538-7600
Fax:         703-538-7676
Mail to:     FDAnews
                         300 N Washington St
                         Ste 200
                         Falls Church VA USA 22046-3431

Media Contact:

Jeff Grizzel FDAnews, 703-538-7668, jgrizzel@fdanews.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com




Internet Technology, Health Care & Hospitals, Medical Pharmaceuticals

Need Help